Active site mutations change the cleavage specificity of neprilysin

Travis Sexton; Lisa J. Hitchcook; David W. Rodgers; Luke H. Bradley; Louis B. Hersh

doi:10.1371/journal.pone.0032343

Active site mutations change the cleavage specificity of neprilysin

Travis Sexton
, Lisa J. Hitchcook
, David W. Rodgers
, Luke H. Bradley
, Louis B. Hersh

Producción científica: Article › revisión exhaustiva

20 Citas (Scopus)

Resumen

Neprilysin (NEP), a member of the M13 subgroup of the zinc-dependent endopeptidase family is a membrane bound peptidase capable of cleaving a variety of physiological peptides. We have generated a series of neprilysin variants containing mutations at either one of two active site residues, Phe ⁵⁶³ and Ser ⁵⁴⁶. Among the mutants studied in detail we observed changes in their activity towards leucine ⁵-enkephalin, insulin B chain, and amyloid β _1-40. For example, NEP ^F563I displayed an increase in preference towards cleaving leucine ⁵-enkephalin relative to insulin B chain, while mutant NEP ^S546E was less discriminating than neprilysin. Mutants NEP ^F563L and NEP ^S546E exhibit different cleavage site preferences than neprilysin with insulin B chain and amyloid ß _1-40 as substrates. These data indicate that it is possible to alter the cleavage site specificity of neprilysin opening the way for the development of substrate specific or substrate exclusive forms of the enzyme with enhanced therapeutic potential.

Idioma original	English
Número de artículo	e32343
Publicación	PLoS ONE
Volumen	7
N.º	2
DOI	https://doi.org/10.1371/journal.pone.0032343
Estado	Published - feb 23 2012

Nota bibliográfica

Funding Information:
Cleavage of physiological peptides was measured via reverse phase high performance liquid chromatography (HPLC) following incubation of the purified NEP or its mutants with 15 µM insulin B chain (Sigma Aldrich), 24 µM Aß (Anaspec), or 64 µM leu-ENK (Sigma) in 100 µL of 20 mM MES, pH 6.5, at 37°C. Reactions were run in triplicate. HPLC was carried out in a Vydac C4 column using a linear gradient from 0.1% trifluoroacetic acid (TFA) in 95% water, 5% acetonitrile to 0.1% TFA in 50% acetonitrile/water at a flow rate of 1 mL/min. Peptides and hydrolysis products were detected at 214 nm and quantified by measuring peak areas. Peptides obtained from HPLC were analyzed on an Applied Biosystems 4800 MALDI TOF/TOF Proteomics Analyzer at the University of Kentucky Proteomics core. This facility is supported in part by grant P20RR020171 from the NIH/NCRR. 1–40

Financiación

Cleavage of physiological peptides was measured via reverse phase high performance liquid chromatography (HPLC) following incubation of the purified NEP or its mutants with 15 µM insulin B chain (Sigma Aldrich), 24 µM Aß (Anaspec), or 64 µM leu-ENK (Sigma) in 100 µL of 20 mM MES, pH 6.5, at 37°C. Reactions were run in triplicate. HPLC was carried out in a Vydac C4 column using a linear gradient from 0.1% trifluoroacetic acid (TFA) in 95% water, 5% acetonitrile to 0.1% TFA in 50% acetonitrile/water at a flow rate of 1 mL/min. Peptides and hydrolysis products were detected at 214 nm and quantified by measuring peak areas. Peptides obtained from HPLC were analyzed on an Applied Biosystems 4800 MALDI TOF/TOF Proteomics Analyzer at the University of Kentucky Proteomics core. This facility is supported in part by grant P20RR020171 from the NIH/NCRR. 1–40

Financiadores	Número del financiador
National Institutes of Health (NIH)
National Institute on Drug Abuse	R01DA002243
National Center for Research Resources

ASJC Scopus subject areas

General

Acceder al documento

10.1371/journal.pone.0032343

Otros archivos y enlaces

Citar esto

@article{e4611226a643484f9b2cfbb6986a931f,

title = "Active site mutations change the cleavage specificity of neprilysin",

abstract = "Neprilysin (NEP), a member of the M13 subgroup of the zinc-dependent endopeptidase family is a membrane bound peptidase capable of cleaving a variety of physiological peptides. We have generated a series of neprilysin variants containing mutations at either one of two active site residues, Phe 563 and Ser 546. Among the mutants studied in detail we observed changes in their activity towards leucine 5-enkephalin, insulin B chain, and amyloid β 1-40. For example, NEP F563I displayed an increase in preference towards cleaving leucine 5-enkephalin relative to insulin B chain, while mutant NEP S546E was less discriminating than neprilysin. Mutants NEP F563L and NEP S546E exhibit different cleavage site preferences than neprilysin with insulin B chain and amyloid {\ss} 1-40 as substrates. These data indicate that it is possible to alter the cleavage site specificity of neprilysin opening the way for the development of substrate specific or substrate exclusive forms of the enzyme with enhanced therapeutic potential.",

author = "Travis Sexton and Hitchcook, \{Lisa J.\} and Rodgers, \{David W.\} and Bradley, \{Luke H.\} and Hersh, \{Louis B.\}",

note = "Funding Information: Cleavage of physiological peptides was measured via reverse phase high performance liquid chromatography (HPLC) following incubation of the purified NEP or its mutants with 15 µM insulin B chain (Sigma Aldrich), 24 µM A{\ss} (Anaspec), or 64 µM leu-ENK (Sigma) in 100 µL of 20 mM MES, pH 6.5, at 37°C. Reactions were run in triplicate. HPLC was carried out in a Vydac C4 column using a linear gradient from 0.1\% trifluoroacetic acid (TFA) in 95\% water, 5\% acetonitrile to 0.1\% TFA in 50\% acetonitrile/water at a flow rate of 1 mL/min. Peptides and hydrolysis products were detected at 214 nm and quantified by measuring peak areas. Peptides obtained from HPLC were analyzed on an Applied Biosystems 4800 MALDI TOF/TOF Proteomics Analyzer at the University of Kentucky Proteomics core. This facility is supported in part by grant P20RR020171 from the NIH/NCRR. 1–40 ",

year = "2012",

month = feb,

day = "23",

doi = "10.1371/journal.pone.0032343",

language = "English",

volume = "7",

number = "2",

}

TY - JOUR

T1 - Active site mutations change the cleavage specificity of neprilysin

AU - Sexton, Travis

AU - Hitchcook, Lisa J.

AU - Rodgers, David W.

AU - Bradley, Luke H.

AU - Hersh, Louis B.

N1 - Funding Information: Cleavage of physiological peptides was measured via reverse phase high performance liquid chromatography (HPLC) following incubation of the purified NEP or its mutants with 15 µM insulin B chain (Sigma Aldrich), 24 µM Aß (Anaspec), or 64 µM leu-ENK (Sigma) in 100 µL of 20 mM MES, pH 6.5, at 37°C. Reactions were run in triplicate. HPLC was carried out in a Vydac C4 column using a linear gradient from 0.1% trifluoroacetic acid (TFA) in 95% water, 5% acetonitrile to 0.1% TFA in 50% acetonitrile/water at a flow rate of 1 mL/min. Peptides and hydrolysis products were detected at 214 nm and quantified by measuring peak areas. Peptides obtained from HPLC were analyzed on an Applied Biosystems 4800 MALDI TOF/TOF Proteomics Analyzer at the University of Kentucky Proteomics core. This facility is supported in part by grant P20RR020171 from the NIH/NCRR. 1–40

PY - 2012/2/23

Y1 - 2012/2/23

N2 - Neprilysin (NEP), a member of the M13 subgroup of the zinc-dependent endopeptidase family is a membrane bound peptidase capable of cleaving a variety of physiological peptides. We have generated a series of neprilysin variants containing mutations at either one of two active site residues, Phe 563 and Ser 546. Among the mutants studied in detail we observed changes in their activity towards leucine 5-enkephalin, insulin B chain, and amyloid β 1-40. For example, NEP F563I displayed an increase in preference towards cleaving leucine 5-enkephalin relative to insulin B chain, while mutant NEP S546E was less discriminating than neprilysin. Mutants NEP F563L and NEP S546E exhibit different cleavage site preferences than neprilysin with insulin B chain and amyloid ß 1-40 as substrates. These data indicate that it is possible to alter the cleavage site specificity of neprilysin opening the way for the development of substrate specific or substrate exclusive forms of the enzyme with enhanced therapeutic potential.

AB - Neprilysin (NEP), a member of the M13 subgroup of the zinc-dependent endopeptidase family is a membrane bound peptidase capable of cleaving a variety of physiological peptides. We have generated a series of neprilysin variants containing mutations at either one of two active site residues, Phe 563 and Ser 546. Among the mutants studied in detail we observed changes in their activity towards leucine 5-enkephalin, insulin B chain, and amyloid β 1-40. For example, NEP F563I displayed an increase in preference towards cleaving leucine 5-enkephalin relative to insulin B chain, while mutant NEP S546E was less discriminating than neprilysin. Mutants NEP F563L and NEP S546E exhibit different cleavage site preferences than neprilysin with insulin B chain and amyloid ß 1-40 as substrates. These data indicate that it is possible to alter the cleavage site specificity of neprilysin opening the way for the development of substrate specific or substrate exclusive forms of the enzyme with enhanced therapeutic potential.

UR - https://www.scopus.com/pages/publications/84857614739

UR - https://www.scopus.com/pages/publications/84857614739#tab=citedBy

U2 - 10.1371/journal.pone.0032343

DO - 10.1371/journal.pone.0032343

M3 - Article

C2 - 22384224

AN - SCOPUS:84857614739

SN - 1932-6203

VL - 7

JO - PLoS ONE

JF - PLoS ONE

IS - 2

M1 - e32343

ER -

Active site mutations change the cleavage specificity of neprilysin

Resumen

Nota bibliográfica

Financiación

ASJC Scopus subject areas

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto